http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011012018-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5859836cd5b65a17aa0963b145287c90 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4525 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 |
| filingDate | 2009-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5aff64c6f7957dd901258dad8157a12b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d834fccb5480d496caea61809909e53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_587d58ec504a4e8e625dea31452865cc |
| publicationDate | 2011-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2011012018-A |
| titleOfInvention | Pharmaceutical composition for oral administration of paroxetine hydrochloride hydrate with suppressed decay delay |
| abstract | An object of the present invention is to provide a pharmaceutical composition of paroxetine hydrochloride hydrate with suppressed decay delay. [Solution] Paroxetine hydrochloride hydrate; At least one excipient selected from the group consisting of lactose, sucrose, D-mannitol, corn starch, partially pregelatinized starch, crystalline cellulose, anhydrous calcium hydrogen phosphate and calcium hydrogen phosphate hydrate; and carmellose At least one disintegrant selected from the group consisting of calcium, low substituted hydroxypropylcellulose and sodium carboxymethyl starch; A pharmaceutical composition for oral administration comprising a) selecting anhydrous calcium hydrogen phosphate as an excipient and selecting at least any one of the disintegrants; b) At least any one of the excipients is selected, and carmellose calcium or low-substituted hydroxypropylcellulose or both are selected as disintegrants. A granulated product obtained by coating paroxetine hydrochloride hydrate with hypromellose may be mixed with calcium hydrogen phosphate as an excipient and sodium carboxymethyl starch as a disintegrant, and tableted. [Selection figure] None |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115350157-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014129239-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014129238-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112641750-A |
| priorityDate | 2009-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.